News for Healthier Living

Mayo Clinic Researchers Identify a Measurable Genetic Mutation as a Significant Predictor of Metastasis and Survival in Pancreatic Cancer

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic mutation -- KRAS circulating tumor DNA (ctDNA) -- strongly indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma (PDAC). The mutation was identified using a readily available and clinically approved blood and abdominal fluid test.

March 19, 2025


March 31 2025

March 30 2025

March 29 2025

March 28 2025

March 27 2025

March 26 2025

March 25 2025

March 24 2025

March 23 2025

March 22 2025

March 21 2025

March 20 2025

March 19 2025

March 18 2025

March 17 2025